Suven Life Sciences announces positive topline results from a Phase-2 study evaluating Samelisant for Excessive Daytime Sleepiness in adult Narcolepsy patients with and without cataplexy.
AI Assistant
Suven Life Sciences Ltd
2023
Announcement
Find Answers
Ask about any part of the document to get insights, explanations, or key details.